VIDA
Live / Applied — Suspended — suspension letter mailed (as of 11 Aug 2025)
What this means for you
Not registered yet, but its 26 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98717456
- Mark type
- Stylized text
- Filed
- 26 Aug 2024
- Attorney of record
- Kristen Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment and prevention of cancer
- Class 009 — Scientific and electric apparatus: Downloadable software for cancer medication dose calculation and monitoring; Downloadable computer application software for mobile devices and computers, namely, software for therapeutic drug monitoring in the fields of cancer treatment, pharmacy, and patient statistics.
- Class 041 — Education and entertainment services: Educational services, namely, providing educational resources and treatment planning in the field of cancer treatment
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the treatment of cancer; research and development in the field of cancer treatment plans; technological research in the field of cancer
- Class 045 — Legal and security services: Providing information in the field of cancer treatment; Medical services in the nature of cancer treatment planning; consultation services in the field of cancer treatment; providing a website featuring information about cancer treatment planning
Owner
- Vivaldi Therapeutics, Inc., Philadelphia, PA, US
Prosecution history
- 11 Aug 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 11 Aug 2025 — LETTER OF SUSPENSION E-MAILED
- 11 Aug 2025 — SUSPENSION LETTER WRITTEN
- 11 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Mar 2025 — NON-FINAL ACTION E-MAILED
- 23 Mar 2025 — NON-FINAL ACTION WRITTEN
- 03 Mar 2025 — ASSIGNED TO EXAMINER
- 17 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Aug 2024 — NEW APPLICATION ENTERED